$62.43
Price
$10.4B
Market Cap
—
P/E Ratio
-59.2
Forward P/E
$-3.48
EPS (TTM)
—
Dividend Yield
$2.1B
Cash
$2.1B
Total Debt
166M
Shares Out
$42.13
$86.74
52-Week Range
Institutional Ownership of Ionis Pharmaceuticals Inc.
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 2.3M | $181M | $34.93 | +78.72% |
Trading Activity for Ionis Pharmaceuticals Inc.
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | +0.2% | 2.3M | $181M | $75.13 | |
| 2026-Q1 | |||||
| SELL | -21.6% | 2.3M | $171M | $80.45 | |
| 2025-Q3 | |||||
| BUY | +0.3% | 2.9M | $190M | $42.85 | |
| 2025-Q2 | |||||
| SELL | -3.1% | 2.9M | $114M | $32.99 | |
| 2025-Q1 | |||||
| SELL | -8.2% | 3.0M | $90M | $32.73 | |
| 2024-Q4 | |||||
| SELL | -6.0% | 3.2M | $114M | $37.86 | |
| 2023-Q4 | |||||
| SELL | -1.6% | 3.5M | $175M | $48.34 | |
| 2023-Q3 | |||||
| SELL | -0.9% | 3.5M | $159M | $40.96 | |
| 2023-Q2 | |||||
| SELL | -0.0% | 3.5M | $145M | $37.27 | |
| 2023-Q1 | |||||
| SELL | +0.0% | 3.5M | $127M | $38.11 | |
| 2022-Q4 | |||||
| BUY | +30.1% | 3.5M | $134M | $42.69 | |
| 2022-Q3 | |||||
| SELL | -0.1% | 2.7M | $120M | $43.24 | |
| 2022-Q2 | |||||
| SELL | -6.8% | 2.7M | $101M | $38.05 | |
| 2022-Q1 | |||||
| BUY | NEW | 2.9M | $108M | $32.46 | |
Insider Trading for Ionis Pharmaceuticals Inc.
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.